Mould & Immunocompromised Patients: Critical Singapore Safety Guide

Why Immunocompromised Patients Face the Highest Risk

A healthy adult inhales an estimated 100 to 1,000 Aspergillus spores every day in tropical Singapore, and clears every one of them silently. Pulmonary alveolar macrophages identify and destroy spores within hours; neutrophils mop up any hyphae that begin to germinate. The system is so robust that aspergillosis is virtually unheard of in healthy people.

That defence collapses when neutrophil counts drop below 500/μL (severe neutropenia), when corticosteroids suppress macrophage function, or when calcineurin inhibitors used after transplant prevent T-cell recognition of fungal antigens. Once a single spore germinates inside the lung, hyphal growth is angioinvasive — the fungus drills into pulmonary blood vessels, causing infarction, haemorrhage and dissemination to brain, sinuses, kidneys and skin within days.

The World Health Organization's 2009 guidelines on indoor dampness and mould explicitly identify immunocompromised individuals as the population requiring the lowest possible spore exposure. The Institute of Medicine's 2004 report Damp Indoor Spaces and Health reaches the same conclusion. There is no safe threshold for this group — only "as low as reasonably achievable."

Highest-Risk Patient Groups

• Acute leukaemia — particularly during induction and consolidation chemotherapy when neutropenia lasts 14–28 days
• Allogeneic stem-cell / bone marrow transplant — the highest-risk group globally; aspergillosis incidence 5–15% with mortality up to 90% if cerebral
• Solid organ transplant — lung (highest), heart, liver, kidney recipients on tacrolimus, cyclosporine or mycophenolate
• HIV with CD4 count below 200 — particularly when also receiving steroids for PCP prophylaxis
• Long-term high-dose corticosteroids — prednisolone above 20 mg/day for more than 3 weeks
• Biologic therapy — anti-TNF (infliximab, adalimumab), anti-IL-6 (tocilizumab), JAK inhibitors, anti-CD20 (rituximab), anti-BTK (ibrutinib)
• Severe COPD on chronic inhaled or oral steroids — at risk of chronic pulmonary aspergillosis
• Cystic fibrosis — at risk of allergic bronchopulmonary aspergillosis (ABPA)
• Diabetes mellitus, poorly controlled — at risk of mucormycosis from Rhizopus species
• Severe burns and ICU patients on broad-spectrum antibiotics

Singapore-Specific Exposure Profile

Singapore's climate is essentially designed for fungal growth. Average outdoor relative humidity is 84% year-round, and indoor humidity in HDB and condo flats typically sits between 70% and 90% unless aggressively dehumidified. Aspergillus fumigatus, A. niger, A. flavus, Penicillium, Cladosporium and Stachybotrys chartarum are all well-documented as endemic indoor isolates in Singapore housing.

Three exposure routes are particularly dangerous for immunocompromised households:

• Air-conditioner biofilm — split-unit evaporator coils run at the dew point, accumulating Cladosporium and Aspergillus biofilm within 6–12 weeks of last servicing. Each compressor cycle aerosolises spores directly into the breathing zone.
• Bomb-shelter and store-room wall cavities — concrete walls without proper vapour barriers harbour hidden Stachybotrys colonies that release spores into adjacent bedrooms whenever the door is opened.
• Bathroom-adjacent bedroom walls — moisture migration through unsealed grout creates colonies on the bedroom side of the shared wall, often invisible until paint blistering appears.

The monsoon transitions in November–January and June–July produce humidity spikes that double indoor spore counts within 48 hours. Patients about to begin a chemotherapy cycle during these months should consider a pre-cycle environmental audit.

Acute Symptoms & Red Flags

Invasive aspergillosis is notoriously hard to diagnose early because symptoms mimic bacterial pneumonia. For an immunocompromised patient living in a home with any visible mould, the threshold for suspicion must be very low. Seek same-day medical attention if any of these appear:

• New fever above 38°C unresponsive to broad-spectrum antibiotics within 72 hours
• Pleuritic chest pain (sharp pain on deep breath)
• Haemoptysis (coughing blood, even small amounts)
• New shortness of breath at rest
• Sinus pain, facial swelling, or black eschar inside the nostril (mucormycosis red flag)
• New visual disturbance or unilateral facial weakness (CNS dissemination)
• Skin lesions with central necrosis (cutaneous dissemination)

Do not wait for the next clinic appointment. Bring a photograph of any visible household mould to the emergency department — it materially changes the empirical antifungal decision.

Long-Term Health Consequences of Continued Exposure

Even when a single acute episode is survived, repeated low-dose exposure has measurable long-term consequences in this population:

• Chronic pulmonary aspergillosis (CPA) — cavitating lesions that mimic tuberculosis on CT, requiring 6 months to lifelong itraconazole or voriconazole, with progressive fibrotic loss of lung volume
• Allergic bronchopulmonary aspergillosis (ABPA) — IgE-mediated airway inflammation causing fixed airflow obstruction and central bronchiectasis
• Hypersensitivity pneumonitis — granulomatous interstitial lung disease that can become irreversible after months of exposure
• Mycotoxin bioaccumulation — ochratoxin A, gliotoxin and aflatoxin exposure has been associated in the clinical literature with persistent fatigue, cognitive impairment ("brain fog"), peripheral neuropathy and accelerated immunosenescence
• Increased post-transplant rejection rates — sub-clinical fungal infection appears to potentiate alloimmune response in solid-organ transplant cohorts
• Reduced 5-year survival — haematology cohorts with documented household mould exposure show measurably lower 5-year overall survival even after the acute infection is treated

The cumulative picture is that mould exposure does not stop being a problem once an acute infection is controlled. It continues to subtract years of life and quality of life across the survivorship period.

Pre-Treatment Home Audit — What to Check

Ideally performed 2–4 weeks before chemotherapy or transplant induction. Either DIY using the checklist below, or book a professional inspection.

• All bathroom ceilings, especially the corner farthest from the exhaust fan
• Wardrobe back walls (pull wardrobe 30 cm from the wall, look and smell)
• Aircon evaporator coil — open the front cover and inspect the fins; black film = biofilm
• Bomb shelter walls, ceiling and door seal
• Bedroom walls adjacent to bathroom or kitchen (look for paint blistering or hairline cracks)
• Under-sink cabinets in kitchen and bathroom
• Window frames and the wall directly below window air-con units
• Behind any wallpaper that was applied over previous paint

For BMT or solid-organ transplant candidates we recommend going further: spore-trap air sampling in the patient's bedroom and a borescope inspection of any wall cavity that was previously affected by water damage. Hidden mould accounts for an estimated 70% of total household contamination.

Hospital-Grade Remediation Protocol for Immunocompromised Households

Standard residential mould removal is not appropriate for this group. The work must follow infection-control principles closer to a hospital construction-site (ICRA Class III/IV) than to a typical home renovation:

• Patient relocated for the entire treatment day plus a clearance period — typically 4–6 hours after work ends
• Negative-pressure containment — work zone sealed with 6-mil polyethylene; HEPA-filtered air scrubber maintains 4–6 air changes per hour at negative pressure to the rest of the home
• Botanical sporicidal antimicrobials only — thymol and citric-acid based blends that break down to water and CO2; no quaternary ammonium, no bleach, no chlorine dioxide (these leave reactive residues that worsen chemo-induced mucositis)
• HEPA-vacuum + wet-wipe protocol — every surface in the work zone, then 1.5 m beyond the containment
• Substrate decision — porous materials with deep colonisation (drywall, ceiling board, gypsum) are removed and replaced rather than cleaned, in line with IICRC S520 and IOM 2004 recommendations
• Post-treatment air sampling — Andersen impactor spore-trap inside and outside the containment; written clearance report comparing indoor to outdoor counts before re-entry is authorised
• HVAC isolation — air-conditioning to the affected zone shut down throughout the work and the coil itself cleaned separately if implicated
• Documentation pack for medical records — pre/post photographs, antimicrobial product safety datasheets, air sampling results, technician PPE log

Coordination with Your Care Team

The most useful thing we can do, beyond the physical work, is provide your specialists with documentation that integrates into your clinical record. We routinely send the post-treatment clearance report directly to oncologists, transplant coordinators, infectious-disease consultants, paediatric haematologists and respiratory physicians at all major Singapore hospitals on request.

Specific items we can prepare on request:

• Pre-treatment hazard assessment letter for insurance pre-authorisation
• Antimicrobial product MSDS confirming residue-free profile suitable for residency by neutropenic patients
• Post-treatment air sampling report with quantified spore counts and species identification
• Re-entry recommendation letter with specific timing
• Six-month follow-up re-inspection report for transplant survivorship clinics

If your specialist wants to speak with our project lead before scheduling, we are happy to arrange a 15-minute call at no charge.

Related Reading

• Mould & Elderly — Immunosenescence in Singapore
• Mould & Asthma Triggers
• Safe to Stay During Mould Removal?
• Singapore Aspergillus & Penicillium Field Study
• Stachybotrys (Black Mould) in Singapore Homes
• Mould Health Risks Pillar